Skip to main content

Advertisement

Open Peer Review Reports for: Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
11 Sep 2012 Submitted Original manuscript
16 Oct 2012 Reviewed Reviewer Report - Oliver Renner
17 Oct 2012 Reviewed Reviewer Report - David Cano
22 Oct 2012 Reviewed Reviewer Report - Francisco X. Real
24 Oct 2012 Reviewed Reviewer Report - Pamela Crowell
10 Dec 2012 Author responded Author comments - Michele Yip-Schneider
Resubmission - Version 2
10 Dec 2012 Submitted Manuscript version 2
17 Jan 2013 Reviewed Reviewer Report - David Cano
23 Feb 2013 Reviewed Reviewer Report - Francisco X. Real
22 Mar 2013 Author responded Author comments - Michele Yip-Schneider
Resubmission - Version 3
22 Mar 2013 Submitted Manuscript version 3
Publishing
11 Apr 2013 Editorially accepted
17 Apr 2013 Article published 10.1186/1471-2407-13-194

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement